DENVER--(BUSINESS WIRE)--Ceragenix Pharmaceuticals, Inc. (OTCB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology today announced that Michael S. Niederman MD, FACP, FCCP, FCCM has joined its scientific advisory board. Dr. Niederman is Professor of Medicine and Vice-Chairman of the Department of Medicine at the State University of New York at Stony Brook and he is also Chairman of the Department of Medicine at Winthrop-University Hospital in Mineola, New York.
